Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06540300 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Repetitive Transcrannial Magnetic Stimulation on Non-Suicidal Self-Injury

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later May 30, 2025 → May 30, 2027
See other at-risk trials from Nanjing Medical University

Record History

  1. Notable Primary completion pushed from May 30, 2025 to May 30, 2027
    • Study completion pushed from Jun 15, 2025 to Jun 15, 2027
    • Interventions: rTMS stimulation of right IPL (Other) to rTMS stimulation of left M1 (Other)
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Non-suicidal self-injury (NSSI) refers to a series of direct and consequently repeated injuries to one's body without suicidal intent. At present, it has become an important issue of mental disorders. This article focuses on the formation mechanism of NSSI and the intervention effect of rTMS on NSSI patients. At the same time, NSSI patients are collected, a treatment plan is designed to complete a two-week treatment, and the results are analyzed. The aim is to provide theoretical basis for the clinical diagnosis and treatment of NSSI, and also to provide reference for the clinical diagnosis and treatment of NSSI patients.
Trial Details
NCT Number NCT06540300
Lead Sponsor Nanjing Medical University
Conditions
(from sponsor)
NSSI
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov